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DoxycyclineCulturing human embryonic stem and induced pluripotent stem cells (hESCs/iPSCs) is one of themost costly and
labor-intensive tissue cultures, as media containing expensive factors/cytokines should be changed every day to
maintain and propagate undifferentiated hESCs/iPSCs in vitro. We recently reported that doxycycline, an anti-
bacterial agent, had dramatic effects on hESC/iPSC survival and promoted self-renewal. In this study, we extend-
ed the effects of doxycycline to a more practical issue to save cost and labor in hESC/iPSC cultures. Regardless of
cultured cell conditions, hESCs/iPSCs in doxycycline-supplemented media were viable and proliferating for at
least 3 days without media change, while none or few viable cells were detected in the absence of doxycycline
in the same conditions. Thus, hESCs/iPSCs supplemented with doxycycline can be cultured for a long period of
time with media changes at 3-day intervals without altering their self-renewal and pluripotent properties, indi-
cating that doxycycline supplementation can reduce the frequency of media changes and the amount of media
required by 1/3. These ﬁndings strongly encourage the use of doxycycline to save cost and labor in culturing
hESCs/iPSCs.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cultures for human embryonic stem and induced pluripotent stem
cells (hESCs/iPSCs) are a useful platform in research and regenerative
medicine (Yu and Thomson, 2008; Reubinoff et al., 2000; Thomson
et al., 1998; Ludwig et al., 2006). However, culturing hESCs/iPSCs is
labor-intensive and requires fastidious culture conditions. Media used
in hESC/iPSC cultures are expensive because they inevitably contain cy-
tokines and molecules to support hESC/iPSC survival and maintenance
of their self-renewing and pluripotent properties. The need to change
media every day makes the hESC/iPSC cultures more costly and labor-
intensive.
We recently reported that doxycycline improves both hESC/iPSC
viability and self-renewal (Chang et al., 2014). These effects of doxycy-
cline are not associated with its antibacterial action but are mediated
by activation of the intracellular PI3K-Akt pathway, which, in addition
to its general cell survival effects, has been reported as the most crucialandMolecular Biology, College
Sungdong-gu, Seoul 133-791,
. This is an open access article undersignal for hESC/iPSC self-renewal (Bendall et al., 2007; Singh et al.,
2012). In this study, we examined if the doxycycline effects can be prac-
tically utilized to save the cost and labor of hESC/iPSC culturing.
2. Materials and methods
2.1. Cell culture
hESCs H9 (WA09; 46, XX; Wicell), HSF6 (UC06; 46, XX; Wicell),
hiPSCs Retro-1(Rv-hiPS 01-1; retroviral iPSC; Harvard), Lenti-1
(IMR90-1; Lentiviral iPSC; UWThomson), and Pro-1 (piPSC-#1; Protein
iPSC; Harvard) were used. More information on the hESC/iPSC lines is
available in supplementary Table S1. The hESCs/iPSCs were cultured
on Matrigel™ (BD Biosciences, Franklin Lakes, NJ) with mTESR™-1
(STEMCELL technology, Vancouver, Canada) or PluriSTEM™ (Millipore,
Billerica, MA) medium with or without doxycycline (1 μg/ml,
Calbiochem, Billerica, MA) following the manufacturer's instructions.
The medium was changed at the indicated time intervals (1–3 days).
The cultures were passaged at every 6th day by dissociating hESC/iPSC
clusters with AccutaseR (STEMCELL technology) and plating at
8 × 104 cells/6-cm dish (2500 cells/cm2) in feeder-free Matrigel™
conditions.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Apoptotic cell death was assessed as the percent of cells positive for
the apoptotic cell-speciﬁc marker Annexin V by direct counting on a
microscope. Annexin V/PI-stained cell populations were further
assessed by using FACS (Canto™ II, BD Biosciences, San Jose, CA) with
an Annexin-V-FLUOS staining kit (Roche, Mannheim, Germany).
2.3. Immunostaining
Cultured cells were ﬁxed with 4% paraformaldehyde in PBS and in-
cubated overnight at 4 °C with primary antibodies: Nanog (polyclonal,
1:200, SantaCruz biotechnologies, Dallas, TX), SSEA4 (polyclonal,
1:500, R & D Systems, Minneapolis, MN), Oct4 (monoclonal, 1:500,
Santa Cruz), and TRA1-60 (monoclonal, 1:200, Millipore). Appropriate
ﬂuorescence-tagged secondary antibodies (Jackson Immunoresearch
Laboratories) were used to visualize the cells. Stained samples were
mounted in VECTASHIELD with DAPI mounting solution (Vector
Laboratories).
2.4. Alkaline phosphatase activity analysis
Alkaline Phosphatase Substrate kit I (Vector) was used to analyze
alkaline phosphatase activity within clusters according to the
manufacturer's instructions.
2.5. Evaluation of pluripotency
Pluripotency of hESCs (H9) cultured for 72 days (12 passages) in
doxycycline-supplemented mTESR™-1 with media changes every
3 days was estimated by in vitro hESC differentiation into three germ
lineages and in vivo teratoma formation. hESCs were induced to differ-
entiate for 2 weeks in ITS media (5 μg/ml recombinant human insulin,
50 μg/ml human transferrin, and 5 μg/ml sodium selenite), then follow-
ed by immunostaining for markers speciﬁc for ectoderm (Nestin;
monoclonal, 1:500, Covance, Richmond, CA), mesoderm (Collagen-1;
polyclonal, 1:1000, AbCam, Cambridge, MA), and endoderm (Foxa2;
polyclonal, 1:500, SantaCruz). In vivo teratoma formation was assessed
by injecting 1 × 106 cells of H9 hESCs under the kidney capsule of skid
mice. Eight weeks later, the resulting tumors were removed, embedded
in parafﬁn, and sections were stained with H&E.
2.6. Karyotyping
Karyotyping was carried out by standard G banding at the NEODIN
Medical Institute (Seoul, Korea).
3. Results and discussion
3.1. hESC survival, growth, phenotypes without media change
All of the current hESC/iPSC culture protocols recommend changing
media, which contains expensive factors/cytokines, every day. On the
basis of doxycycline-mediated hESC/iPSC survival and self-renewal
(Chang et al., 2014), we postulated that the interval of media changes
can be lengthened if doxycycline is added. Thus, the aim of this study
was to test whether doxycycline-supplemented hESC/iPSC cultures
can be propagated with media changes at longer intervals, thus saving
time and cost.
To this end, we ﬁrst compared cell viability and growth of H9 hESCs
cultured in the absence and presence of doxycycline without a media
change for several days. Doxycycline supplementation may have differ-
ent effects depending on the total cell density and level of local cell-to-
cell contact (single cell dissociates or cell clusters). Thus we examined
the doxycycline effects at two different culture states, by treating doxy-
cycline (1) right after plating single cell dissociates of hESCs and(2) 3 days after plating (cell clusters formed by cell proliferation for ini-
tial 3 days with media change daily without doxycycline)(the experi-
mental procedures are schematized in Fig. 1a and d). H9 cell clusters
were dissociated into 1–5 cells by using AccutaseR and plated on
Matrigel™ (2500 cells/cm2 in 6-cm dish) in mTESR™-1 medium with-
out and with doxycycline (1 μg/ml). The culture status was examined
every day without changing the media. Representative phase-contrast
images and undifferentiatedmarker expressions over the culture period
without medium change are shown in Suppl. Fig. S1. In the control,
doxycycline (−) medium, the number of cells increased slightly for
2 days after plating (4099± 453 cells/cm2 at day 2, n = 5 independent
experiments for all cell counts shown in Fig. 1) but then decreased, and
all cells diedwithin 4 days after the lastmedia changed (Fig. 1b). By con-
trast, the increases in cell numberwere greater and continued for 3 days
in cells grown in doxycycline (+) medium (11,405± 1386 cells/cm2 at
day 3). The cultures were maintained for 7 days without changing
media. At day 3 after the media change, healthy clusters (on average
70 ± 7 cells/cluster, n = 26 clusters) expressing the hESC/iPSC marker
alkaline phosphatase (AP) formed in doxycycline-supplemented cul-
tures. The clusters in the control cultures were much smaller (41 ± 5
cells/cluster, n = 26) and apoptotic with condensed and fragmented
nuclei (Fig. 1c and data not shown). The apoptotic clusters in control
cultures did not express AP (Fig. 1c) and were about to detach from
the culture surface. The similar ﬁndings were observed when the
doxycycline supplementation effects were tested in the cell clusters
formed 3 days after cell plating (Fig. 1e,f). Reduced apoptosis in the
presence of doxycycline for 3 days without a media change was further
conﬁrmed by Annexin V+ (early apoptotic) and Annexin V+/PI+ for
apoptotic cell populations using immunocytochemistry (Fig. 1g) and
ﬂuorescence-activated cell sorting (FACS) (Fig. 1h) analyses.
3.2. Growth of hESCs/iPSCs in doxycycline-supplemented cultures with
media changes at 3-day intervals
The ﬁndings observed in both the dissociated cells and cell clusters
(Fig. 1) indicate that hESCs/iPSCs can probably be propagated with
media changes at 3-day intervals if doxycycline is added. To test it, H9
hESCs were cultured in doxycycline-supplemented mTESR™-1 with
medium changes every 3 days (Dox+/3d) for 30 days with cell pas-
sages every 6 days (total 5 passages). In these culture conditions with
multiple cell passages, the cells expanded (Fig. 2a) and maintained
healthy cell clusters of authentic hESC/iPSC shapes (such as high
nucleus/cytoplasm ratio and prominent nucleoli) (Fig. 2b), which
were indistinguishable from cultures with media changes every day
(dox−/1d)(data not shown). In total, the cell number increased by
3684-fold during the 5 passages while the population doubling level
(PDL) was maintained in every passage (PDL, 3.18 ± 0.04 on average)
(Fig. 2c). The cell expandability was comparable or identical to that in
doxycycline (−) mediumwithmedia changes every day (dox−/1d, av-
erage PDL: 3.20 ± 0.06) andmuch greater than that in doxycycline (−)
cultures with media changes every 2 days (dox−/2d, average PDL:
1.43 ± 0.19). Other hESC (HSF6) and iPSC (Retro-1, Lenti-1, and Pro-
1) lines could also be cultured in dox+/3d conditions with cell growth
and culture status that were indistinguishable from cultures in dox(−)/
1d conditions (Fig. 2d-g and data not shown).
3.3. Self-renewal and pluripotency of hESCs long-term after culturing in
doxycycline-supplemented media with media change at 3-day intervals
Wenext testedwhether the self-renewal and pluripotent properties
of hESCs were maintained in the long-term after culturing with
dox+/3d. H9 hESCs continuously expanded for 12 passages (Fig. 3a).
The cell growth rates estimated by PDL at late passages did not differ
signiﬁcantly from those of early passages (for instance, 3.17 ± 0.35 at
passage 2 vs. 2.96 ± 0.15 at passage 12, n = 3 independent experi-
ments). We further tested the doxycycline effects in PluriSTEM™,
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Fig. 2. hESCs/iPSCs can be propagated in doxycycline-supplemented media with media change at 3-day intervals. The hESCs/iPSCs were cultured in doxycycline (+) or (−) media with
media changes at the indicated time intervals. The culturesweremaintained for 30 days (5 passages)with cell passages at every 6 days. a, cell growth curve. Total viable cellswere counted
on the last day of every passage from 5 independent experiments. The curves shown are the natural logarithm (Ln) of accumulated total cell numbers in the doxycycline (+)media with
media changes at 3-day intervals (dox+/3d) and in the doxycycline (−) media with media changes every day (dox−/1d), every 2 days (dox−/2d), and every 3 days (dox−/3d).
*Signiﬁcantly different from the respective values of dox+/3d at the same cell passages at p b 0.001, Student's t-test, n = 5 independent experiments. b, Representative H9 hESC clusters
cultured in dox+/3d at passage 5. Inset, high-powered image of the boxed area. Scale bar, 50 μm. c-g, Comparison of cell growths between dox+/3d and dox−/1d conditions in various
hESCs/iPSCs. Cell expansion was estimated by PDL (from 5 independent cultures), calculated as log(N/No)/log2, where N is the number of cells at the end of each passage and No is the
number of cells plated initially.
611M.-Y. Chang et al. / Stem Cell Research 15 (2015) 608–613advertised as a medium with which hESCs/iPSCs can be cultured with
media change at 2 day intervals. However, hESC cultures in the condi-
tions applied in this study (passaging by plating cell dissociates) were
not maintained in this medium with media change at 2 day intervals,
if doxycyclinewas not supplemented (data not shown). Supplementing
PluriSTEM™with doxycycline resulted in a similar extent of cell growth
with media changes every 3 days (Fig. 3a). Cells after 12 passages
expressed the pluripotent cell-speciﬁc markers AP, Oct4, Nanog,Fig. 1. Effects of doxycycline on hESC survival, growth, and phenotype maintenance in the abs
dish) inmTESR™-1medium. Doxycycline (1 μg/ml) was add (+) or not (−) right after (a–c) o
until all cells died. The experimental procedures are schematized (a) and (d). Total cell numbe
contrast and immunostaining images of hESC/iPSC-speciﬁc AP (c), SSEA4, and Nanog (f) after
different from the respective doxycycline-untreated controls (−) at the same cell culture d
populations were further assessed by immunocytochemistry against Annexin V during day
immunostained images and FACS plots were taken at day 3 without a media change. *Signi
same cell culture day (e; p b 0.05, n = 3 independent experiments) or at day 3 (f; p b 0.001, nSSEA4, and TRA1-60 (Fig. 3b). The undifferentiated hESC/iPSC-speciﬁc
marker expressions were also manifested in the other hESC and hiPSCs
after 5 passages with dox+/3d (Suppl. Fig. S2). FACS analyses (Fig. 3c)
further showed that most cells (N94%) at passage 12 expressed
Oct4 and SSEA4. A normal karyotype was maintained after 12 passages
with the dox+/3d protocol (Fig. 3d). In addition, hESCs maintained
with dox+/3d differentiated into three germ layers such as neuro-
ectodermal (Nestin+), mesodermal (Collagen1+; bone, tendon,ence of daily media changes. Dissociated H9 hESCs were plated (2500 cells/cm2 per 6-cm
r 3 days after cell plating (d-h), and the cultures were maintained without a media change
r (b,e) and the hESC-speciﬁc marker expression (c,f) were assessed. Representative phase
3 days without a media change. Insets, enlarged images of the boxed areas. *Signiﬁcantly
ay at p b 0.05, n = 5 independent experiments, Student's t-test. g and h, Apoptotic cell
s 1–3 (e) and FACS (f) for Annexin+/PI+ cells at day 3 without a media change. The
ﬁcantly different from the respective doxycycline (DOX)-untreated controls (−) at the
= 3 independent experiments), Student's t-test. Scale bars, 50 μm.
Fig. 3. Self-renewal and pluripotent hESC properties maintained long after culturing in doxycycline-supplementedmedia with media changes at 3-day intervals. H9 hESCs were cultured
for 12 passages in doxycycline-supplemented mTESR™-1 or PluriSTEM™medium with media changes every 3 days. a, Cell growth curves. b and c, Immunocytochemical (b) and FACS
(c) analyses showing the expression of markers of undifferentiated hESCs in H9 cultures at passage 12. Blue populations in (c) are negative controls that were not treated with primary
antibodies. Scale bars, 50 μm. d, Unaltered karyotype of H9 cells after 12 passages in dox+/3d conditions. Chromosomes were analyzed from 20 randomly chosen nuclei. e and f,
pluripotency of hESCs estimated by in vitro differentiation (e) and in vivo teratoma formation (f). e, Immunocytochemical analysis to examine differentiation into cells speciﬁc to the
three germ layers. In vitro differentiation of H9 cells maintained for 12 passages in dox+/3d conditions was induced as described in ‘Materials and Methods’. The differentiated cultures
were stained for markers speciﬁc for ectoderm (Nestin), mesoderm (Collagen I), and endoderm (Foxa2). The cells were counterstainedwith DAPI. Scale bars= 50 μm. f, Teratoma forma-
tion in themouse kidney capsules induced by injecting H9 cells at passage 12. Parafﬁn-embedded teratomaswere stainedwith haematoxylin and eosin. The teratomas included cell types
that represent ectoderm, mesoderm, and endoderm, indicating pluripotency. Scale bars = 100 μm.
612 M.-Y. Chang et al. / Stem Cell Research 15 (2015) 608–613cartilage) and endodermal (Foxa2+) lineages upon an in vitro differen-
tiation condition (Fig. 3e). The pluripotency of the hESCs was further
conﬁrmed by in vivo formation of teratoma, in which neural (ecto-
derm), cartilage (mesoderm), and blood vessel (endoderm) structures
were detected (Fig. 3f). These ﬁndings strongly support culturing
hESCs/iPSCs in doxycycline-supplemented media with changes every
3 days.As shown in Fig. 1, H9 hESCs in doxycycline-supplemented media
were viable for 6–7 days without a media change. When the medium
was replaced after up to 6 days, the culture returned to a healthy status
within several days. These cultures could be maintained for a long peri-
od of time without any trouble or alterations of the hESC self-renewal
and pluripotent properties (data not shown). These ﬁndings indicate
that doxycycline supplementation is also useful for maintaining hESC/
613M.-Y. Chang et al. / Stem Cell Research 15 (2015) 608–613iPSC cultures, evenwhenmedia changes are not allowed for long period
(b6 days).
We show in this study doxycycline effects in the feeder-free culture
condition. Doxycycline treatment also improves cell survival and main-
tenance of undifferentiated hESCs/iPSCs cultured on the feeder layer of
mouse embryonic ﬁbroblast (MEF) (Chang et al., 2014). Viability of the
hESCs/iPSCs onMEF feeder is highly dependent on the feeder cell condi-
tion. Notably, in addition to doxycycline effects on hESCs/iPSCs, it also
improves the viability ofMEF feeder cells (data not shown). Thus, doxy-
cycline supplementation allows for the hESCs/iPSCs cultures on the
feeder withmedium changes at 3-day intervals or even longer intervals
for long period (data not shown). In conclusion, based on the observa-
tions in this study, we strongly recommend using doxycycline supple-
mentation for hESCs/iPSCs cultures to save expense and work, as well
as eliminating the need for media changes on weekends and holidays.Acknowledgements
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